Science supporting the art of medicine: Improving the management of breathlessness

Palliative Medicine

Volumn 27, Issue 6, 2013, Pages 483-485

  Booth, Sara ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; OPIATE;

DRUG SAFETY; DYSPNEA; EDITORIAL; HUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRESCRIPTION; QUALITY OF LIFE; SLEEP DISORDERED BREATHING; SLEEP QUALITY; TRANSLATIONAL RESEARCH;

DYSPNEA; HUMANS; PALLIATIVE CARE;

EID: 84877998233     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216313488490     Document Type: Editorial

References (7)

1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012 ; 185 (4). 435-452
2. Gracely RH, Undem BJ, Banzett RB. Cough, pain and dyspnoea: similarities and differences. Pulm Pharmacol Ther. 2007 ; 20 (4). 433-437
3. Murtagh FEM, Addington-Hall JM, Donohoe P, et al. Symptom management in patients with established renal failure managed without dialysis. J Renal Care. 2006 ; 32: 93-98
4. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007 ; 3 (5). 455-461
5. Opioids for persistent pain: good practice. London: The British Pain Society ; 2010 :
6. Booth S, Farquhar M, Gysels M, et al. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative phase 1 study. Palliat Support Care. 2006 ; 4: 287-293
7. Spathis A Breathlessness management in clinical practice. Booth S Moffat CM Burkin J, ed. Springer-Verlag ;